Camptodactyly syndrome, Guadalajara type 2

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:1326OMIM:211920Q87.1
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Camptodactyly syndrome, Guadalajara type 2 is an extremely rare genetic disorder characterized by a combination of camptodactyly (permanent flexion contractures of the fingers), distinctive facial features, and skeletal abnormalities. This condition was first described in patients from Guadalajara, Mexico, and is distinguished from Guadalajara type 1 by its specific constellation of clinical features. The syndrome affects multiple body systems. Key clinical features include camptodactyly, short stature, microcephaly (abnormally small head), intellectual disability, and characteristic craniofacial anomalies such as a flat face, small mouth (microstomia), and abnormalities of the ears. Skeletal manifestations may include abnormalities of the vertebrae, short neck, and other bone anomalies. Additional features can involve the musculoskeletal system with muscle hypoplasia or atrophy, as well as neck and spinal abnormalities. Due to the extreme rarity of this condition, there is no specific treatment available. Management is supportive and symptomatic, focusing on addressing individual clinical manifestations. This may include orthopedic interventions for skeletal abnormalities, physical and occupational therapy for hand function and motor development, and educational support for intellectual disability. Genetic counseling is recommended for affected families. The condition has been reported in very few families worldwide, making large-scale clinical studies challenging.

Clinical phenotype terms— hover any for plain English:

Labial hypoplasiaHP:0000066Short 2nd toeHP:0001885Patellar hypoplasiaHP:0003065Cuboid-shaped vertebral bodiesHP:0004634Short 3rd toeHP:0005643Short 5th toeHP:0011917
Inheritance

Autosomal recessive

Passed on when both parents carry the same gene change; often skips generations

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Camptodactyly syndrome, Guadalajara type 2.

View clinical trials →

No actively recruiting trials found for Camptodactyly syndrome, Guadalajara type 2 at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Camptodactyly syndrome, Guadalajara type 2 community →

No specialists are currently listed for Camptodactyly syndrome, Guadalajara type 2.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Camptodactyly syndrome, Guadalajara type 2.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Camptodactyly syndrome, Guadalajara type 2Forum →

No community posts yet. Be the first to share your experience with Camptodactyly syndrome, Guadalajara type 2.

Start the conversation →

Latest news about Camptodactyly syndrome, Guadalajara type 2

No recent news articles for Camptodactyly syndrome, Guadalajara type 2.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Camptodactyly syndrome, Guadalajara type 2

What is Camptodactyly syndrome, Guadalajara type 2?

Camptodactyly syndrome, Guadalajara type 2 is an extremely rare genetic disorder characterized by a combination of camptodactyly (permanent flexion contractures of the fingers), distinctive facial features, and skeletal abnormalities. This condition was first described in patients from Guadalajara, Mexico, and is distinguished from Guadalajara type 1 by its specific constellation of clinical features. The syndrome affects multiple body systems. Key clinical features include camptodactyly, short stature, microcephaly (abnormally small head), intellectual disability, and characteristic craniofa

How is Camptodactyly syndrome, Guadalajara type 2 inherited?

Camptodactyly syndrome, Guadalajara type 2 follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Camptodactyly syndrome, Guadalajara type 2 typically begin?

Typical onset of Camptodactyly syndrome, Guadalajara type 2 is neonatal. Age of onset can vary across affected individuals.